Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial
Treatment of non-union remains challenging and often necessitates augmentation of the resulting defect with an autologous bone graft (ABG). ABG is limited in quantity and its harvesting incurs an additional surgical intervention leaving the risk for associated complications and morbidities. Therefor...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
30 May 2018
|
| In: |
Trials
Year: 2018, Volume: 19 |
| ISSN: | 1468-6694 |
| DOI: | 10.1186/s13063-018-2681-9 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s13063-018-2681-9 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13063-018-2681-9 |
| Author Notes: | Michael C. Tanner, Raban Heller, Fabian Westhauser, Matthias Miska, Thomas Ferbert, Christian Fischer, Simone Gantz, Gerhard Schmidmaier and Patrick Haubruck |
Search Result 1
Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority...
Universitätsbibliothek Heidelberg 04 Jun. 2018 BioMed Central 04 Jun. 2018
Article (Journal)
Online Resource